Price (delayed)
$120.54
Market cap
$19.2B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.15
Enterprise value
$20.28B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
There are no recent dividends present for ILMN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.